LLY
749.85
+1.61%↑
JNJ
177.08
-0.6%↓
ABBV
210.45
+0.22%↑
UNH
348.61
+8.84%↑
NVO
54.26
-0.09%↓
LLY
749.85
+1.61%↑
JNJ
177.08
-0.6%↓
ABBV
210.45
+0.22%↑
UNH
348.61
+8.84%↑
NVO
54.26
-0.09%↓
LLY
749.85
+1.61%↑
JNJ
177.08
-0.6%↓
ABBV
210.45
+0.22%↑
UNH
348.61
+8.84%↑
NVO
54.26
-0.09%↓
LLY
749.85
+1.61%↑
JNJ
177.08
-0.6%↓
ABBV
210.45
+0.22%↑
UNH
348.61
+8.84%↑
NVO
54.26
-0.09%↓
LLY
749.85
+1.61%↑
JNJ
177.08
-0.6%↓
ABBV
210.45
+0.22%↑
UNH
348.61
+8.84%↑
NVO
54.26
-0.09%↓
24u
Huidig
Min
3.23
Max
3.58
Aanbevelingen | Buy |
---|---|
12 Maanden Prognose | +290.84% upside |
Volgende Winsten | 12 nov 2025 |
---|
Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.
10 mrt 2025, 02:12 UTC
Checkpoint Controlling Shareholder Fortress Has Agreed to Vote in Favor of Transaction >524715.BY
DJ
Lezen
10 mrt 2025, 02:12 UTC
Sun Pharma, Checkpoint Transaction Expected to Complete in 2Q 2025 >524715.BY
DJ
Lezen
10 mrt 2025, 02:11 UTC
Sun Pharma, Checkpoint, Fortress Biotech Enter Into Royalty Agreement >524715.BY
DJ
Lezen
10 mrt 2025, 02:11 UTC
Checkpoint Shareholders Entitled to Receive Up to Additional $0.70 if Cosibelimab if Approved in EU Prior to Certain Deadlines >524715.BY
DJ
Lezen
10 mrt 2025, 02:10 UTC
Checkpoint Shareholders to Receive Upfront Cash Payment of $4.10/Share, Contingent Value Right >524715.BY
DJ
Lezen
10 mrt 2025, 02:10 UTC
Sun Pharma to Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
Lezen
10 mrt 2025, 02:06 UTC
Sun Pharma To Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
Lezen
Prijswijziging
By TipRanks
12 Maanden Prognose
Gemiddelde 14.5 USD 290.84%
Hoogste 17 USD
Laagste 12 USD
Gebaseerd op 2 Wall Street-analisten die 12-maands prijsdoelen bieden voor Fortress Biotech Inc - Dist. in de afgelopen 3 maanden.
By TipRanks
Buy
2 ratings
2
Buy
0
Hold
0
Sell
Gebaseerd op 2 analisten die aandelenratings hebben gegeven aan Fortress Biotech Inc - Dist in de afgelopen 3 maanden.
$